Sunway Medical Centre named in the inaugural Newsweek's Asia's Top Private Hospitals 2025 ranking

January 23, 2025 10:28 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

SUBANG JAYA, Malaysia, Jan. 23, 2025 /PRNewswire/ -- Sunway Medical Centre, Sunway City (SMC), has been honoured in the inaugural Newsweek's Top Private Hospitals 2025 ranking and recognised as the top hospital in Malaysia for four out of five procedures: knee surgery and knee replacement, shoulder surgery, cataract surgery, and eye refractive surgery.

(From left) Dato Lau Beng Long, Sunway Healthcare Group President; Dr Jeffrey Jaya Raj, Head of Orthopaedic Department, Sunway Medical Centre, Sunway City (SMC); Dr Peh Khaik Kee, Clinical Head of Ophthalmology, SMC; Dr Low Kwai Siong, Medical Director, SMC; Tan Mei Shin, Senior Director of Business Development & Corporate Communications; SMC; Choong Sui Ching, General Manager of Orthopaedic Services, SMC
(From left) Dato Lau Beng Long, Sunway Healthcare Group President; Dr Jeffrey Jaya Raj, Head of Orthopaedic Department, Sunway Medical Centre, Sunway City (SMC); Dr Peh Khaik Kee, Clinical Head of Ophthalmology, SMC; Dr Low Kwai Siong, Medical Director, SMC; Tan Mei Shin, Senior Director of Business Development & Corporate Communications; SMC; Choong Sui Ching, General Manager of Orthopaedic Services, SMC

Additionally, it is ranked 2nd in Asia for cataract surgery, and 3rd in Asia for refractive eye surgery. SMC is also featured in the top 10 of Asia's ranking for hip surgery and hip replacement (6th); knee surgery and knee replacement (6th); and shoulder surgery (10th).

"We are honoured to be ranked among the best in Asia for key specialities such as orthopaedics and ophthalmology. It is a testament to our relentless pursuit of clinical excellence.

"The recognition also underscores the dedication of medical specialists and other healthcare professions in providing a high standard of multidisciplinary care and treatment to our Malaysian and international patients," said Dato' Lau Beng Long, President of Sunway Healthcare Group.

As Malaysia's largest private quaternary hospital, SMC is the first hospital in Malaysia to obtain three major hospital-wide accreditations: Joint Commission International (JCI) Accreditation, The Gold Seal of Approval from the United States; the Australian Council on Healthcare Standards (ACHS); and the Malaysian Society for Quality in Health (MSQH).

The hospital offers 28 Centres of Excellence, supported by a diverse multidisciplinary team that provides holistic and personalised treatment.

Sunway Eye Centre, one of SMC's Centres of Excellence, offers services across various subspecialties including cataract and refractive ophthalmology, cornea transplant, medical retinal and uveitis, glaucoma, oculoplastic ophthalmology, and paediatric ophthalmology.

SMC's Orthopaedic Centre, together with Robotic Surgery and Minimally Invasive Surgery (MIS) Centre, have achieved remarkable milestones, especially in robotic hip and knee replacement surgeries, which earned recognition in the Malaysia Book of Records. This achievement underscores the centre's expertise and unwavering commitment to innovation.

This latest rankings builds on SMC's success in the Newsweek World's Best Hospitals 2024 rankings, where it was named one of the top 250 hospitals globally. The hospital was also featured in Newsweek's Best Specialist Hospitals Asia Pacific list for two consecutive years, 2023 and 2024.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.